$20,000 is available for medical, scientific or social research to improve outcomes for people with haemophilia, von Willebrand disorder or other related bleeding disorders, and/or those with medically acquired blood borne viruses.
The funding round is for research projects to be commenced in the 2019 – 2020 financial year.